These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33331403)

  • 1. Sensitivity and specificity in prevalence studies: The importance of considering uncertainty.
    Izbicki R; Diniz MA; Bastos LS
    Clinics (Sao Paulo); 2020 Dec; 75():e2449. PubMed ID: 33331403
    [No Abstract]   [Full Text] [Related]  

  • 2. Approaches to uncertainty in exposure assessment in environmental epidemiology.
    Spiegelman D
    Annu Rev Public Health; 2010; 31():149-63. PubMed ID: 20070202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of epidemiologic information in targeted surveillance for population inference.
    Wells SJ; Ebel ED; Williams MS; Scott AE; Wagner BA; Marshall KL
    Prev Vet Med; 2009 May; 89(1-2):43-50. PubMed ID: 19269705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sources of uncertainty in dose-response modeling of epidemiological data for cancer risk assessment.
    Stayner L; Bailer AJ; Smith R; Gilbert S; Rice F; Kuempel E
    Ann N Y Acad Sci; 1999; 895():212-22. PubMed ID: 10676419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty in risk characterization of weak carcinogens.
    Yamaguchi N
    Ann N Y Acad Sci; 1999; 895():338-47. PubMed ID: 10676426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of over-diagnosis in serological testing. Implications for communications strategies.
    Biggeri A; Forni S; Braga M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiologic critique of current microbial risk assessment practices: the importance of prevalence and test accuracy data.
    Gardner IA
    J Food Prot; 2004 Sep; 67(9):2000-7. PubMed ID: 15453595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying and reporting uncertainty from systematic errors.
    Phillips CV
    Epidemiology; 2003 Jul; 14(4):459-66. PubMed ID: 12843772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty in risk assessment. Current efforts and future hopes.
    Bailer AJ
    Ann N Y Acad Sci; 1999; 895():367-72. PubMed ID: 10676429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological studies in developing countries.
    Dhamija RK
    J Assoc Physicians India; 2000 Nov; 48(11):1132, 1135. PubMed ID: 11310406
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating uncertainty to strengthen epidemiologic data for use in human health risk assessments.
    Burns CJ; Wright JM; Pierson JB; Bateson TF; Burstyn I; Goldstein DA; Klaunig JE; Luben TJ; Mihlan G; Ritter L; Schnatter AR; Symons JM; Yi KD
    Environ Health Perspect; 2014 Nov; 122(11):1160-5. PubMed ID: 25079138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reporting and interpreting uncertainty in epidemiological studies].
    Biggeri A; Catelan D; Barbone F
    Epidemiol Prev; 2011; 35(1):51-2. PubMed ID: 21436496
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis.
    Leeflang MM; Bossuyt PM; Irwig L
    J Clin Epidemiol; 2009 Jan; 62(1):5-12. PubMed ID: 18778913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying how tests reduce diagnostic uncertainty.
    Coulthard MG
    Arch Dis Child; 2007 May; 92(5):404-8. PubMed ID: 17158858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irritable bowel syndrome: epidemiology and diagnosis.
    Ron Y
    Isr Med Assoc J; 2003 Mar; 5(3):201-2. PubMed ID: 12725144
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interpretation of epidemiologic studies].
    Flahault A
    Rev Prat; 2013 Oct; 63(8):1153-8. PubMed ID: 24298837
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
    Yu AS; Keeffe EB
    Am J Gastroenterol; 2003 May; 98(5):955-6. PubMed ID: 12809814
    [No Abstract]   [Full Text] [Related]  

  • 18. The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance.
    Kost GJ
    Arch Pathol Lab Med; 2021 Jul; 145(7):797-813. PubMed ID: 33684204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re. Sensitivity Analyses Without Assumptions.
    Popham F; Whitley E
    Epidemiology; 2019 Sep; 30(5):e31. PubMed ID: 31373936
    [No Abstract]   [Full Text] [Related]  

  • 20. When can the result of epidemiologic research not eliminate the need to invoke the precautionary principle?
    Weiss NS
    J Evid Based Dent Pract; 2006 Mar; 6(1):16-8. PubMed ID: 17138390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.